Data spanning the past 90 days through February 19, 2026 reveals that Sunshine Biopharma's three principal insider shareholders consist of Cfo/Secretary Camille Sebaaly (4 shares), Chief Executive Officer Steve N. Slilaty (3 shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Camille Sebaaly | Cfo/Secretary | 4 | 01 Dec, 2022 |
| Steve N. Slilaty | Chief Executive Officer | 3 | 05 Mar, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 04 Mar, 2024 | Steve N. Slilaty | Series B Preferred Stock | A | 100,000 | $0.10 | 3 | D | P |
| 08 Feb, 2024 | Steve N. Slilaty | Series B Preferred Stock | A | 20,000 | $0.10 | 1 | D | P |
| 30 Nov, 2022 | Camille Sebaaly | Common Stock | A | 30,000 | $0.76 | 4 | D | P |
| 30 Nov, 2022 | Camille Sebaaly | - | - | 4 | D | |||
| 03 Jun, 2022 | Camille Sebaaly | Common Stock | A | 25,000 | $1.22 | 4 | D | P |
| 18 Feb, 2022 | Steve N. Slilaty | Series B Preferred Stock | D | 990,000 | $0.10 | 0 | D | D |
| 18 Feb, 2022 | Steve N. Slilaty | - | - | 0 | D | |||
| 06 Jan, 2021 | Steve N. Slilaty | Common Stock | A | 20,000,000 | $0.00 | 0 | D | A |
| 06 Jan, 2021 | Camille Sebaaly | - | - | 0 | D | |||
| 06 Jan, 2021 | Camille Sebaaly | Common Stock | A | 20,000,000 | $0.00 | 0 | D | A |
| 06 Jan, 2021 | Abderrazzak Merzouki | Common Stock | A | 20,000,000 | $0.00 | 0 | D | A |
| 17 Jun, 2020 | Steve N. Slilaty | Series "B" Preferred Stock | A | 500,000 | $0.10 | 0 | D | A |
| 11 Sep, 2019 | Camille Sebaaly | Common Stock | A | 11,000,000 | $0.00 | 0 | D | A |
| 02 Sep, 2019 | Steve N. Slilaty | Common Stock | A | 13,000,000 | $0.00 | 0 | D | A |
| 02 Sep, 2019 | Camille Sebaaly | Common Stock | A | 13,000,000 | $0.00 | 0 | D | A |
| 27 Aug, 2018 | Steve N. Slilaty | Common Stock | A | 38,000,000 | $0.00 | 0 | D | A |
| 27 Aug, 2018 | Camille Sebaaly | Common Stock | A | 38,000,000 | $0.00 | 0 | D | A |
| 27 Aug, 2018 | Abderrazzak Merzouki | Common Stock | A | 38,000,000 | $0.00 | 0 | D | A |
| 27 Aug, 2018 | Abderrazzak Merzouki | - | - | 0 | D | |||
| 20 Jun, 2018 | Steve N. Slilaty | Common Stock | A | 27,000,000 | $0.00 | 0 | D | A |